Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

BUY
$0.51 - $7.56 $1,581 - $23,436
3,100 Added 8.32%
40,371 $18,000
Q2 2022

Aug 17, 2022

SELL
$0.43 - $1.24 $2,838 - $8,184
-6,600 Reduced 15.04%
37,271 $22,000
Q1 2022

May 27, 2022

BUY
$0.74 - $1.79 $1,480 - $3,580
2,000 Added 4.78%
43,871 $52,000
Q4 2021

May 26, 2022

BUY
$1.69 - $2.46 $70,761 - $103,002
41,871 New
41,871 $73,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Quantum Private Wealth, LLC Portfolio

Follow Quantum Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantum Private Wealth, LLC with notifications on news.